Novartis AG
3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

Abstract:

The present disclosure provides a compound of Formula (I'): ##STR00001## or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R.sub.x, X.sub.1, X.sub.2, and R.sub.1 are as defined herein, and methods of making and using same.